What are the latest news in the femtech market?
Download our beautiful pitch about the femtech market
In our femtech market deck, you will find everything you need to understand the market
The femtech market is moving fast, and this blog post tracks the latest news that matters most for investors, founders, and operators.
We constantly update this femtech market news page so readers can quickly understand what changed, who moved, and why each update matters.
The latest femtech market news shows strong momentum in fertility, pelvic health, menopause, breast cancer detection, and women’s health AI.
And if you want to better understand this new industry, you can download our pitch covering the femtech market.
Insights
- The biggest femtech market news is not only about apps anymore. FDA-cleared AI, smart implants, and clinical devices are becoming central to women’s health innovation.
- Fertility remains one of the strongest femtech market segments, with AI embryo assessment, rural access programs, and new reproductive care platforms all gaining attention.
- The femtech market is becoming more clinical. Breast cancer AI, urinary incontinence implants, and postmenopausal bone health devices show that serious medical needs are attracting capital.
- Government interest is rising. The UK femtech fund is small, but the signal matters because public healthcare systems can help femtech companies scale faster.
- Large consumer health platforms are becoming femtech distribution channels. Hims & Hers adding Flo and Natural Cycles shows how women’s health apps can reach broader audiences.
- AI is now a repeated theme in the femtech market, but the strongest products connect AI with clear clinical use cases, proprietary data, or easier care navigation.
- Menopause and midlife care are expanding beyond symptom relief. Coral and Osteoboost show that the femtech market is also targeting long-term health risks.
- Asia is becoming more visible in the femtech market, with HealthFab and Flora showing momentum in menstrual wellness, workplace health, consumer apps, and women’s health data.
- Smaller femtech funding rounds still matter because many early companies are building in underfunded categories like brain health, vaginal health, and reproductive care coordination.
This chart, included in our femtech market deck, shows how Flo Health is capturing share in femtech
Summary table of the latest news in the femtech market
We define the femtech market as technology-enabled products and services that address women’s reproductive and other female-specific health needs.
We include solutions focused on menstrual and cycle health, fertility and contraception, pregnancy and postpartum, menopause, pelvic and sexual health, and clinically oriented tools for conditions that predominantly or uniquely affect women, such as breast and gynecological cancers.
We exclude general-purpose health, wellness, fitness, mental health, and consumer apps that are not specifically designed around women’s biology, care pathways, or life stages.
You can also read our detailed analysis to understand what are the quarterly updates in the femtech market.
| Piece of news | Category | Exact date | Source |
|---|---|---|---|
| Alife won FDA clearance for AI embryo assessment in IVF. | Regulations & Policies | May 28, 2026 | Alife Health |
| Hims & Hers added Natural Cycles and Flo to subscriber benefits. | Partnerships | May 28, 2026 | Business Wire |
| Evvy launched an AI vaginal-health advisor trained on 100,000 tests. | Product launches | May 20, 2026 | Femtech Insider |
| UroMems raised $60M to prepare its smart incontinence implant for approval. | Strategic Investments | May 13, 2026 | PR Newswire |
| Carrot added OB/GYN offices to fertility benefits for rural access. | Market expansions | May 10, 2026 | Carrot |
| HealthFab raised $2.4M to expand beyond reusable period underwear. | Fundraisings | May 5, 2026 | Femtech Insider |
| Flora raised $1.5M to scale women’s health data products across Asia. | Fundraisings | May 4, 2026 | Femtech Insider |
| ScreenPoint secured $16M to scale AI breast cancer detection. | Fundraisings | April 17, 2026 | PR Newswire |
| ONTO Health raised $20M and moved fertility care toward the Gulf. | Fundraisings | April 17, 2026 | Femtech Insider |
| The UK launched a £1.5M femtech fund inside its women’s health strategy. | Regulations & Policies | April 15, 2026 | GOV.UK |
| Osteoboost raised $8M for its FDA-cleared wearable for postmenopausal bone loss. | Fundraisings | April 15, 2026 | Osteoboost |
| myStoria raised $1.625M for AI-plus-human reproductive care navigation. | Fundraisings | March 31, 2026 | myStoria |
| Coral added CAD $4M for virtual menopause and midlife care. | Fundraisings | March 31, 2026 | Yahoo Finance |
| Prickly Pear passed $600K for AI-powered women’s brain health. | Fundraisings | March 26, 2026 | PR Newswire |
| WHOOP launched women-specific blood testing and cycle prediction upgrades. | Product launches | March 10, 2026 | WHOOP |
Latest news of the femtech market
Alife won FDA clearance for AI embryo assessment in IVF
Regulations & Policies
What happened?
Alife Health received FDA clearance for Embryo Predict, an AI tool that helps fertility specialists evaluate embryos during IVF. Embryo Predict uses embryo images and data patterns to support a difficult fertility care decision: which embryo to transfer.
When was it?
Alife Health announced the FDA clearance on May 28, 2026.
Why is it big news?
This is big femtech market news because FDA-cleared AI in IVF shows that fertility software is moving into regulated clinical infrastructure.
Why should you care?
If you’re an investor in the femtech market, Alife Health shows that fertility AI can reduce regulatory risk when the product fits a real clinical workflow.
If you’re an entrepreneur in the femtech market, Alife Health shows that clinics may adopt AI faster when the software works with existing lab equipment.
As this chart shows, and as featured in our femtech market deck, search interest in femtech has increased significantly
Hims & Hers brought Flo and Natural Cycles into its subscriber benefits
Partnerships
What happened?
Hims & Hers expanded its subscriber benefits program with eight new health and wellness partners. The partner list includes Natural Cycles and Flo Health, two well-known women’s health and cycle-focused products.
When was it?
Hims & Hers announced the partnership expansion on May 28, 2026.
Why is it big news?
This is big femtech market news because large consumer health platforms can give women’s health apps a faster path to mainstream distribution.
Why should you care?
If you’re an investor in the femtech market, this partnership shows that distribution can be as valuable as product features.
If you’re an entrepreneur in the femtech market, Hims & Hers shows that bundles, benefits, and memberships can become strong growth channels.
This chart, included in our femtech market deck, compares the main business model options for menopause telehealth platforms
Evvy launched an AI vaginal-health advisor built on more than 100,000 tests
Product launches
What happened?
Evvy launched EvvyAI, an AI advisor for vaginal health. EvvyAI is trained on data from more than 100,000 vaginal microbiome tests.
When was it?
EvvyAI launched on May 20, 2026.
Why is it big news?
This is big femtech market news because vaginal health remains underserved, and Evvy is using a large women’s health dataset to make care guidance easier to understand.
Why should you care?
If you’re an investor in the femtech market, Evvy shows how proprietary datasets can become a moat in women’s health AI.
If you’re an entrepreneur in the femtech market, Evvy shows that AI is stronger when the product is built around specific women’s health data.
This market map, featured in our femtech market deck, highlights top companies and startups in the femtech market
UroMems raised $60M for a smart implant for stress urinary incontinence
Strategic Investments
What happened?
UroMems raised a $60 million strategic investment from Ajax Health Fund I. UroMems will use the capital to support pivotal trials and commercial preparation for UroActive, a smart automated implant for stress urinary incontinence.
When was it?
UroMems announced the strategic investment on May 13, 2026.
Why is it big news?
This is big femtech market news because pelvic health is moving beyond apps and therapy into advanced medical devices.
Why should you care?
If you’re an investor in the femtech market, UroMems shows that serious medtech capital is moving into pelvic health conditions that were historically underfunded.
If you’re an entrepreneur in the femtech market, UroMems shows that hardware, clinical trials, and regulatory planning can also attract large funding in women’s health.
This chart, featured in our femtech market deck, illustrates how revenue is divided among customer segments in the femtech market
Carrot added OB/GYN offices to make fertility benefits easier to access
Market expansions
What happened?
Carrot announced that vetted OB/GYNs can now provide early fertility care inside its employer-sponsored fertility benefit. This can include first evaluations, testing, monitoring, and related fertility care.
When was it?
Carrot announced the expansion on May 10, 2026.
Why is it big news?
This is big femtech market news because fertility access is still uneven, especially for people who live far from fertility specialists.
Why should you care?
If you’re an investor in the femtech market, Carrot shows that access and care navigation can create value in fertility benefits.
If you’re an entrepreneur in the femtech market, Carrot shows that connecting local doctors, specialists, benefits, and patient data can make fertility care easier to use.
This chart, included in our femtech market deck, shows annual VC investment in femtech startups
HealthFab raised $2.4M to grow from period underwear into menstrual wellness
Fundraisings
What happened?
India’s HealthFab raised about $2.4 million in Series A funding. HealthFab started with reusable period underwear and is now expanding into broader menstrual wellness.
When was it?
HealthFab announced the funding on May 5, 2026.
Why is it big news?
This is big femtech market news because India can support large menstrual health brands when products are affordable, practical, and locally distributed.
Why should you care?
If you’re an investor in the femtech market, HealthFab shows that menstrual health can become a scalable consumer category in large emerging markets.
If you’re an entrepreneur in the femtech market, HealthFab shows that one focused period-care product can become the starting point for a broader women’s health platform.
This chart, included in our femtech market deck, shows annual funding in femtech startups
Flora raised $1.5M to scale women’s health data products across Asia
Fundraisings
What happened?
Japan-based Flora raised about $1.5 million to expand its women’s health platform. Flora works across employee wellbeing, women’s health data services, and a consumer app.
When was it?
Flora announced the funding on May 4, 2026.
Why is it big news?
This is big femtech market news because Flora is building around the women’s health data gap across several Asian markets.
Why should you care?
If you’re an investor in the femtech market, Flora shows that Asia already has local companies building cross-border women’s health platforms.
If you’re an entrepreneur in the femtech market, Flora shows that workplace health, consumer apps, and data products can support each other when the platform is designed well.
In our femtech market deck, we tell you what to focus on
ScreenPoint secured $16M to scale AI breast cancer detection
Fundraisings
What happened?
ScreenPoint Medical announced $16 million in funding. The amount includes $14 million from existing investors and $2 million in non-dilutive research grants.
When was it?
ScreenPoint Medical announced the funding on April 17, 2026.
Why is it big news?
This is big femtech market news because AI for breast cancer detection is moving from pilot projects toward real clinical deployment.
Why should you care?
If you’re an investor in the femtech market, ScreenPoint Medical shows that breast imaging AI companies with real usage and clinical evidence can become stronger investment targets.
If you’re an entrepreneur in the femtech market, ScreenPoint Medical shows that clinical AI needs trust, workflow fit, and evidence, not only a strong model.
In our femtech market deck, we identify pain points entrepreneurs should prioritize
ONTO Health raised $20M and linked fertility care with longevity
Fundraisings
What happened?
ONTO Health raised a $20 million Series A co-led by ARTIS and Humania. ONTO Health combines fertility care, AI diagnostics, clinical automation, and longevity science.
When was it?
ONTO Health announced the funding on April 17, 2026.
Why is it big news?
This is big femtech market news because ONTO Health is positioning fertility as part of longer-term women’s health, not only as a single treatment journey.
Why should you care?
If you’re an investor in the femtech market, ONTO Health shows that fertility platforms can expand into broader women’s health and longevity markets.
If you’re an entrepreneur in the femtech market, ONTO Health shows that fertility can be a strong entry point into a longer patient relationship.
In our femtech market deck, we dentify risks investors and builders need to be aware of
The UK launched a £1.5M femtech fund inside its women’s health strategy
Regulations & Policies
What happened?
The UK government included a £1.5 million Femtech challenge fund in its renewed Women’s Health Strategy for England. The fund is designed to speed up adoption of innovations that can improve women’s healthcare.
When was it?
The UK government announced the renewed strategy on April 15, 2026.
Why is it big news?
This is big femtech market news because a national government is treating femtech as part of public healthcare reform.
Why should you care?
If you’re an investor in the femtech market, the UK femtech fund shows that public-sector adoption could become a meaningful growth path.
If you’re an entrepreneur in the femtech market, the UK femtech fund shows that government-backed pilots can become useful proof points for healthcare system sales.
In our femtech market deck, we ensure you have the latest information
Osteoboost raised $8M for its wearable for postmenopausal bone loss
Fundraisings
What happened?
Osteoboost Health closed an $8 million financing round. Osteoboost Health will use the capital to scale manufacturing and commercialization of its prescription wearable for low bone density.
When was it?
Osteoboost Health announced the financing on April 15, 2026.
Why is it big news?
This is big femtech market news because postmenopausal bone loss is a serious long-term health issue, not only a quality-of-life concern.
Why should you care?
If you’re an investor in the femtech market, Osteoboost Health shows that menopause care can include regulated medical devices and measurable clinical outcomes.
If you’re an entrepreneur in the femtech market, Osteoboost Health shows that life-stage health products can be strongest when the product targets a clear medical risk.
In our femtech market deck, we like to quantify things to make things easier to understand
myStoria raised $1.625M for AI-plus-human reproductive care navigation
Fundraisings
What happened?
myStoria raised a $1.625 million seed round led by Graphite Ventures. myStoria helps patients organize reproductive health information and navigate fragmented care with AI plus trained human support.
When was it?
myStoria announced the seed round on March 31, 2026.
Why is it big news?
This is big femtech market news because many reproductive health patients still manage records, symptoms, appointments, referrals, and insurance without enough support.
Why should you care?
If you’re an investor in the femtech market, myStoria shows that care navigation can become valuable infrastructure when patients face complex journeys.
If you’re an entrepreneur in the femtech market, myStoria shows that painful coordination work can be a strong startup wedge.
This chart, included in our femtech market deck, shows how Flo Health is capturing share in femtech
Coral added CAD $4M for virtual menopause and midlife care
Fundraisings
What happened?
Coral raised an additional CAD $4 million for its virtual care model. Coral focuses on perimenopause, menopause, weight management, and midlife health.
When was it?
Coral announced the additional financing on March 31, 2026.
Why is it big news?
This is big femtech market news because menopause care is becoming a broader clinical category in North America.
Why should you care?
If you’re an investor in the femtech market, Coral shows that midlife women’s health can become a platform opportunity.
If you’re an entrepreneur in the femtech market, Coral shows that menopause care needs to address hormones, metabolism, weight, sleep, and long-term health together.
As this chart shows, and as featured in our femtech market deck, search interest in femtech has increased significantly
Prickly Pear passed $600K for AI-powered women’s brain health
Fundraisings
What happened?
Prickly Pear Health expanded its pre-seed funding to more than $600,000. The round included participation from Emmeline Ventures and existing investors.
When was it?
Prickly Pear Health announced the expanded pre-seed funding on March 26, 2026.
Why is it big news?
This is big femtech market news because women’s brain health during hormonal transitions is still an early but important category.
Why should you care?
If you’re an investor in the femtech market, Prickly Pear Health shows that cognitive symptoms linked to hormones may become a new women’s health segment.
If you’re an entrepreneur in the femtech market, Prickly Pear Health shows that underserved symptoms can become startup opportunities when people experience the problem often.
This chart, included in our femtech market deck, compares the main business model options for menopause telehealth platforms
WHOOP launched women-specific blood testing and cycle prediction upgrades
Product launches
What happened?
WHOOP announced a Women’s Health Specialized Blood Biomarker Panel, hormonal symptom prediction features, and a menstrual cycle modeling white paper. WHOOP is connecting women’s health data with recovery, sleep, stress, and cycle context.
When was it?
WHOOP announced the new women’s health features on March 10, 2026.
Why is it big news?
This is big femtech market news because wearables are moving beyond basic cycle tracking into more personalized women’s health interpretation.
Why should you care?
If you’re an investor in the femtech market, WHOOP shows that women-specific health features can help wearable companies stand out.
If you’re an entrepreneur in the femtech market, WHOOP shows that users need data explained around biology, life stage, and daily context.
Related blog posts
- The latest developments in the femtech market
- How strong is fundraising in the femtech market right now?
- What is the true size of the femtech market?
- How funding activity has evolved in the femtech market
- What are the key fundraising trends in the femtech market?
- All the funding deals announced in the femtech market
- A complete list of business models in the femtech market
- Which companies have raised the most funding in the femtech market?
- Which companies are the most valued in the femtech market?
